These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36922788)

  • 1. Thrombocytosis in patients with spondyloarthritis: a case-control study.
    Deng L; Zheng P
    BMC Musculoskelet Disord; 2023 Mar; 24(1):195. PubMed ID: 36922788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Levels and Antibodies Against TNF-blockers in Spondyloarthritis and Rheumatoid Arthritis are Associated with the Activity but they do Not Predict it.
    Padilla-Martínez EM; Romero-Sanchez C; Bello-Gualtero JM; Mesa-Betancourt AM; Bautista-Molano W; Valle-O R
    Curr Rheumatol Rev; 2019; 15(4):329-335. PubMed ID: 31284866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive clinical-genetic model of long-term non-response to tumor necrosis factor-alpha inhibitor therapy in spondyloarthritis.
    Polo Y La Borda J; Campos J; Sanz J; Andréu JL; Mulero J; Sánchez A
    Int J Rheum Dis; 2019 Aug; 22(8):1529-1537. PubMed ID: 31119895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort.
    Ciurea A; Scherer A; Exer P; Bernhard J; Dudler J; Beyeler B; Kissling R; Stekhoven D; Rufibach K; Tamborrini G; Weiss B; Müller R; Nissen MJ; Michel BA; van der Heijde D; Dougados M; Boonen A; Weber U;
    Arthritis Rheum; 2013 Dec; 65(12):3096-106. PubMed ID: 23983141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Clinical and MRI Effect of TNF-α Inhibitors in Spondyloarthritis Patients With Hip Involvement: A Real-World Observational Clinical Study.
    Zhang K; Zheng Y; Han Q; Liu Y; Wang W; Ding J; Wang Y; Zhang B; Jia J; Zheng M; Zheng Z; Zhu P
    Front Immunol; 2021; 12():740980. PubMed ID: 34659233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the treatment of uveitis in patients with spondyloarthritis - is it the time for biologic therapy?
    Mitulescu TC; Trandafir M; Dimăncescu MG; Ciuluvică RC; Popescu V; Predețeanu D; Istrate S; Voinea LM
    Rom J Ophthalmol; 2018; 62(2):114-122. PubMed ID: 30206554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fever as an initial manifestation of spondyloarthritis: A retrospective study.
    Byun SJ; Bae WH; Jung SM; Lee SW; Park YB; Song JJ
    PLoS One; 2017; 12(9):e0184323. PubMed ID: 28910361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential value of fibrinogen to albumin ratio (FAR) in the assessment of inflammation in spondyloarthritis.
    Ding Y; Xue L
    BMC Musculoskelet Disord; 2022 Sep; 23(1):864. PubMed ID: 36109740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associated Factors with the Severity of Hip Involvement in Spondyloarthritis and Efficacy of TNF α Inhibitors in these Patients.
    Slouma M; Rahmouni S; Dhahri R; Cheour E; Gharsallah I; Metoui L; Louzir B
    Curr Rheumatol Rev; 2022; 18(1):58-63. PubMed ID: 34636315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of subcutaneous TNF inhibitors and its clinical significance in real-life setting in patients with spondyloarthritis.
    Hiltunen J; Parmanne P; Sokka T; Lamberg T; Isomäki P; Kaipiainen-Seppänen O; Peltomaa R; Uutela T; Pirilä L; Taimen K; Kauppi MJ; Yli-Kerttula T; Tuompo R; Relas H; Kortelainen S; Paalanen K; Asikainen J; Ekman P; Santisteban A; Vidqvist KL; Tadesse K; Romu M; Borodina J; Elfving P; Valleala H; Leirisalo-Repo M; Rantalaiho V; Kautiainen H; Jokiranta TS; Eklund KK;
    Rheumatol Int; 2022 Jun; 42(6):1015-1025. PubMed ID: 34357455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hip and Shoulder Involvement and Their Management in Axial Spondyloarthritis: a Current Review.
    López-Medina C; Castro-Villegas MC; Collantes-Estévez E
    Curr Rheumatol Rep; 2020 Jul; 22(9):53. PubMed ID: 32705356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment With Tumor Necrosis Factor Inhibitors Is Associated With a Time-Shifted Retardation of Radiographic Sacroiliitis Progression in Patients With Axial Spondyloarthritis: 10-Year Results From the German Spondyloarthritis Inception Cohort.
    Torgutalp M; Rios Rodriguez V; Proft F; Protopopov M; Verba M; Rademacher J; Haibel H; Sieper J; Rudwaleit M; Poddubnyy D
    Arthritis Rheumatol; 2022 Sep; 74(9):1515-1523. PubMed ID: 35437900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of procoagulant potential in patients with reactive thrombocytosis and its association with platelet count.
    Rottenstreich A; Shai E; Kleinstern G; Spectre G; Varon D; Kalish Y
    Eur J Haematol; 2018 Mar; 100(3):286-293. PubMed ID: 29240268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidisciplinary Team Led by Joint Surgeons to Rapidly Identify Spondyloarthritis.
    Wang D; Yu X; Shi X; Ma H; Zhang H; Liu B; Fang L; Lv J; Zhang K; Bai X; Ren B
    Altern Ther Health Med; 2023 Jan; 29(1):231-237. PubMed ID: 36150014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Takayasu Arteritis and Spondyloarthritis: Coincidence or Association? A Study of 14 Cases.
    Rivière E; Arnaud L; Ebbo M; Allanore Y; Claudepierre P; Dernis E; Ziza JM; Miceli-Richard C; Philippe P; Richez C; Soubrier M; Belkhir R; Seror R; Mariette X; Pavy S;
    J Rheumatol; 2017 Jul; 44(7):1011-1017. PubMed ID: 28412700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute anterior uveitis and other extra-articular manifestations of spondyloarthritis.
    Mitulescu TC; Popescu C; Naie A; Predeţeanu D; Popescu V; Alexandrescu C; Voinea LM
    J Med Life; 2015; 8(3):319-25. PubMed ID: 26351533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and economic burden of extra-articular manifestations in ankylosing spondylitis patients treated with anti-tumor necrosis factor agents.
    Gao X; Wendling D; Botteman MF; Carter JA; Rao S; Cifaldi M
    J Med Econ; 2012; 15(6):1054-63. PubMed ID: 22563743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A referable clinical pattern of spondyloarthritis-associated uveitis.
    Mitulescu CT; Popescu CC; Oprea CL; Predețeanu D; Istrate S; Ciuluvică R; Voinea LM
    Rom J Ophthalmol; 2018; 62(2):155-161. PubMed ID: 30206560
    [No Abstract]   [Full Text] [Related]  

  • 19. Undifferentiated spondyloarthritis vs ankylosing spondylitis and psoriatic arthritis: a real-life prospective cohort study of clinical presentation and response to treatment.
    Paramarta JE; De Rycke L; Ambarus CA; Tak PP; Baeten D
    Rheumatology (Oxford); 2013 Oct; 52(10):1873-8. PubMed ID: 23861532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brief Report: Clinical Course Over Two Years in Patients With Early Nonradiographic Axial Spondyloarthritis and Patients With Ankylosing Spondylitis Not Treated With Tumor Necrosis Factor Blockers: Results From the German Spondyloarthritis Inception Cohort.
    Poddubnyy D; Haibel H; Braun J; Rudwaleit M; Sieper J
    Arthritis Rheumatol; 2015 Sep; 67(9):2369-75. PubMed ID: 26017497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.